3-Year Nemolizumab Data: Early Responders Hit EASI-90 and Lasting Itch Relief
About 80% of early nemolizumab responders reached EASI-90 by week 152, and half achieved completely clear skin at 3 years in the ARCADIA extension analysis.
Topic
Il 31 Inhibition
Topic